chrisvoncsefalvay/vaers-outcomes huggingface dataset:
covid arm that was swollen and sore arm from shoulder to elbow; swollen covid arm; chills; Flu like symptoms; A covid arm; Inappropriate schedule of vaccine administered; arm had big welt at the injection site and lasted 10 days; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE REACTION (A covid arm), VACCINATION SITE URTICARIA (arm had big welt at the injection site and lasted 10 days), VACCINATION SITE PAIN (covid arm that was swollen and sore arm from shoulder to elbow) and VACCINATION SITE SWELLING (swollen covid arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: flu shot (had similar reaction as COVID-19 vaccination). Past adverse reactions to the above products included Adverse reaction with flu shot. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), ALPRAZOLAM (XANAX), VITAMIN D3, LOVASTATIN and TIZANIDINE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE REACTION (A covid arm), VACCINATION SITE URTICARIA (arm had big welt at the injection site and lasted 10 days), VACCINATION SITE PAIN (covid arm that was swollen and sore arm from shoulder to elbow), VACCINATION SITE SWELLING (swollen covid arm), CHILLS (chills) and PYREXIA (fever). On 22-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE REACTION (A covid arm), VACCINATION SITE PAIN (covid arm that was swollen and sore arm from shoulder to elbow), VACCINATION SITE SWELLING (swollen covid arm), CHILLS (chills) and PYREXIA (fever) outcome was unknown and VACCINATION SITE URTICARIA (arm had big welt at the injection site and lasted 10 days) had resolved.            The patient reported experiencing fever, chills, flu like symptoms and a Covid arm that was swollen and sore from shoulder to elbow. The arm had big welt at the injection site and lasted 10 days. The patient reported of developing a similar reaction after the flu shot as well. The symptoms had resolved, lasting 10 days.  No treatment information was provided.
Day of injection and thru Day 2-c/o aches "not feeling right" Redness. Day 3- Marked swelling and erythema at the site. Fever. Day 4- s/s resolved.
Patient reported dizziness 10 minutes after COVID 19 Vaccine.  Patient?s legs elevated and vitals sign monitored every 5 minutes.   Inital blood pressure 87/49  with heart rate of 102.   Patient was discharged home once symptoms subsided and blood pressure was 125/74 with heart rate of 90. Instructed patient to drink fluids.
Information has been received from an office manager concerning a female (age unknown), who, on an unspecified date, was vaccinated with a first dose of Gardasil. Subsequently, the patient experienced syncope. The patient did not pass out but felt like she was going to. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. This is one of two reports received from the same source. Additional information has been requested.
Dizziness, Myalgia & Fever  Narrative:  Dizzy, fever 102,2, myalgia; took tylenol; recovered.
Ache in her hand; Felt pain all over; She felt like she had fibromyalgia attach; Body ache all over; Her arm was really red for 3 or 4 days at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Ache in her hand), PAIN (Felt pain all over), FIBROMYALGIA (She felt like she had fibromyalgia attach), MYALGIA (Body ache all over) and VACCINATION SITE ERYTHEMA (Her arm was really red for 3 or 4 days at the injection site.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Ache in her hand), PAIN (Felt pain all over), FIBROMYALGIA (She felt like she had fibromyalgia attach), MYALGIA (Body ache all over) and VACCINATION SITE ERYTHEMA (Her arm was really red for 3 or 4 days at the injection site.). In April 2021, PAIN IN EXTREMITY (Ache in her hand), FIBROMYALGIA (She felt like she had fibromyalgia attach), MYALGIA (Body ache all over) and VACCINATION SITE ERYTHEMA (Her arm was really red for 3 or 4 days at the injection site.) had resolved. At the time of the report, PAIN (Felt pain all over) had resolved.            In Concomitant  products Blood pressure medications were reported. No Treatment details were reported.; Sender's Comments: This case concerns a 72-year-old, female patient with no relevant medical history, who experienced the unexpected event of fibromyalgia, pain in extremity and pain along with expected  events of myalgia and vaccination site erythema. The event occurred approximately 1 day after the second dose of Moderna COVID-19 Vaccine. The rechallenge was not applicable as events occurred after second dose and no further dosing was reported or planned, based on information provided.The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
about to get the second dose more than 60 days after the first one; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (about to get the second dose more than 60 days after the first one) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (about to get the second dose more than 60 days after the first one). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (about to get the second dose more than 60 days after the first one) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications are not provided. Treatment information does not provided.
Pt recvd 1st dose of Hep B vax on FEB92 w/o incident; 15MAR92 recvd 2nd dose of vax & 10 days later exp joint pain, arthralgia, fatigue, flushing & paresthesia, transient photosensitivity; dec lt knee jerk;
Next evening started to develop severe tinnitus left greater than right ear.  Pulsatile.  Lasted 2 weeks and slowly has improved, but still severe.  Brain fog?
Pt reported itchiness at 1345. BP was 162/100 mmHg, HR 73 bpm, and spo2% 96%. Patient given water. Patient given oral dihpenhydramine oral solution 25 mg/10 ml (2 doses). Patient reassessed at 1408: BP  190/108 mmHg, HR 70 bpm, and spo2 98%. Patient reassessed at  1423.: BP 148/94, HR 69, spo2 98%. Patient educated on seeing primary care provider for high blood pressure and reaction to shrimp. Patient educated on carrying bendaryl with him. At approx. 1424, pt left facility with steady gait and unlabored respirations.
patient has a swollen mass under his armpit, low grade fever, body aches, and leg pain
48 hours after my 3rd shot of Moderna  I had vaginal bleeding.   The blood was fresh, light colored like from an open wound.   It lasted about 60 to 70 minutes.   The flow was light but continuous.   Then it stopped & I have had nothing since.   I am 20 years past menopause & this was a shocking experience.   It occurred the first night at 2.30 am of a mini vacation in another state.   For 3 days I felt I was living in a nightmare thinking it was another form of cancer.   I never connected it to the booster shot.   On the 5th day after it happened when I had returned home, i found information online from 2 doctors stating that they had complaints from numerous women of bleeding after Covid shots including women years & even decades past menopause.    If I had known that there was a possibility of such an occurance I would not have suffered the nightmare of 3 days & nights of worry.
Pt states 1.5 hours after 1st dose of moderna vaccine her ears started to feel muffled and could not hear as well
Pain, redness, swelling at injection site since day of vaccination. Also fatigue; sleeping 10-12 hours per night since vaccination date.
Osteoarthritis; In beginning she couldn't bend; had  itchiness in joints; cold; had soreness in joints; fever(99-100F); chills; This spontaneous case was reported by a consumer and describes the occurrence of OSTEOARTHRITIS (Osteoarthritis), MOBILITY DECREASED (In beginning she couldn't bend), PRURITUS (had  itchiness in joints), NASOPHARYNGITIS (cold) and ARTHRALGIA (had soreness in joints) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced MOBILITY DECREASED (In beginning she couldn't bend), PRURITUS (had  itchiness in joints), NASOPHARYNGITIS (cold), ARTHRALGIA (had soreness in joints), PYREXIA (fever(99-100F)) and CHILLS (chills). In May 2021, the patient experienced OSTEOARTHRITIS (Osteoarthritis). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 09-Jul-2021 for Pain, at a dose of 1 dosage form. At the time of the report, OSTEOARTHRITIS (Osteoarthritis), MOBILITY DECREASED (In beginning she couldn't bend), PRURITUS (had  itchiness in joints), NASOPHARYNGITIS (cold), ARTHRALGIA (had soreness in joints), PYREXIA (fever(99-100F)) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: high (High) Fever-99-100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details are not provided by the Reporter. On APR2021 Patient experienced chills, cold, and fever(99-100F). Also had soreness and itchiness in joints. since 25 JUNE 2021 Patient started experiencing joint pain in the right thumb. In the beginning she couldn't bend and pain was worse at night. Patient contacted a Rheumatologist and tried to use cream and Advil also used heat and cold but nothing changed. Patient has an appointment with a Rheumatologist on 16JUL2021.   This case was linked to MOD-2021-046299 (Patient Link).
Pt developed increased sleeping and temperature to 104.3 R. Pt was irritable. Decreased PO intake. All within 8 hours after immunization. Upon exam vesicular lesions noted in post pharyngeal probable coxsackie A-16 virus. Pt to take Tylenol/Motrin. Fluids, rest.
APPROX 30 HOURS AFTER DOSE, PT DEVELOPED RED RASH SIMILAR TO SUNBURN ON UPPER TORSO/CHEST AREA. PT REPORTS FEELING ITCHY AND INFLAMMED. VISUALLY LOOKED LIKE SUNBURN.
Swelling in lymph node in rt armpit.  Swelling and redness of arm and chest. Prescribed Clynimyocin and Benadryl. Symptoms subsided in 10 days.
Patient got a rash around the site the injection was given two days later and also had nerve pain. She went to Urgent Care at this time and states she was treated for Shingles.
Intense pain began in arm at injection site within an hour of receiving the vaccination. Shot was given very high on the arm.  No redness or bruising.  Pain is so bad it hurts to lift arm above head for a week after shot.  Taking anti-inflammatory medications.
Macular erythematous rash to injection site 5 x 6 cm in size, circular shape, well circumscribed.   In addition the patient developed several small 1 x 1 cm erythematous macules with irregular shape and poorly defined borders distally throughout the right arm and forearm.
7/12/99 tingling & patchy numbness in extremities;8/27/99 improved, decreased frequency;dx post vaccination myelitis or neuritis;
started running fever evening of 10MAY94;ax t102 @ bedtime;parent gave APAP;pt awake 3-4x during noc;felt hot;no temp taken given APAP x2;11MAY94 5PM had t103.9 ax redness on rt arm & pruritis;went to minor ER t104.6;had allergic react;
I went into labor 4 hours after the vaccine. I delivery  my child 1:40AM on 8/26/2021. My baby weight 3IBS and 13 ounces. The estimated due was 10/28/2021.
hair started falling out; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (hair started falling out) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included Back surgery (about 4 years ago). Concurrent medical conditions included Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy.   On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ALOPECIA (hair started falling out). At the time of the report, ALOPECIA (hair started falling out) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Claritin she was taking this at the time her hair was falling out, takes when her allergies were flaring up. Allergy Drops (unknown name) will likely have to start using again in the summer.  Patient was 46 when her hair started falling out. Doctors are saying that patient are getting alopecia from wearing wigs and people are saying it was due to things without vitamin d and iron. If Patient had regular alopecia, she would have bald spots. She was so mad about her hair. She cries about all day about her hair. Treatment drug was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-723206 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2023: Live follow up- QE number updated. Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723206: Bivalent case.
patient with shortness of breath. Patient was tested at her facility was negative.  Patient does have a history of hypertension and dyslipidemia.  Patient is a status post bilateral below the knee amputation- this was due to recurrent blood clots in her lower extremities and complications from those blood clot she is not currently anticoagulated. She has been given Levaquin and Lasix in the ED, Foley has been placed and has been diuresing well.  ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
At 1525, medical emergency response system activated for a patient that was having an anaphylactic response to one of the vaccines that she had received. The patient had hives on her lower legs, she was struggling to catch her breath, felt her throat was closing, and was dizzy. The patient was given epinephrine 0.3mg at 1526 in her left vastus lateralis. Oxygen was administered to the patient as her O2 level was slowly dropping and she appeared in respiratory distress. BP at that time was 145/90, O2 97%, pulse 84.    Vitals were monitored at the following times:  15:30: 127/72, pulse 66, 98% 2L 15:33: 120 78,84, 99% RA 15:42: 128/ 87   The patient's PCP was notified of the event. She recommended the patient seek care at the ER due to possible rebound from the epi. The patient agreed to us calling EMS to transport her.    1549: 135/87, pulse 70, O2 99% RA   Fire department arrived: 1549 EMS arrived: 1605   Nursing Assessment:  Airway: Open Breathing: Labored Circulation: Pulse present Mentation: Alert Skin: Hives     She was transported to the emergency department via ambulance at 1605.
Sore throat; drippy nose; mild headache that is not worth mentioning; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (drippy nose) and HEADACHE (mild headache that is not worth mentioning) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (drippy nose) and HEADACHE (mild headache that is not worth mentioning). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (drippy nose) and HEADACHE (mild headache that is not worth mentioning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  No concomitant medications were reported. Treatment information was not provided.
the day after i had tightness in my chest when i reclined or laid down. for two days after injection i had very bad lower back pain. to the point where i had to sit and put heat on it and could not walk around normally. and now my the tips of my thumbs are tingling and when i use them to push something or slpick something up. i get a sharp pain to the point that i stoped using my thumb to pick things up.
Case number PHEH2013US026176 is an initial spontaneous report received from a health care professional on 17 DEC 2013. This report refers to an 18 month old male infant. His medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN 2013/2014 (batch number: 1310001, expiry date: 31 MAY 2013) intramuscularly at a dose of 0.5 ml on 19 NOV 2013. No adverse event was reported following this administration error.
Had typical flu symptoms after vaccination, including severe chills, nauseous, achy, weak. Cant remember when had flu last. Stayed in bed night, almost fainted in morning, but probably because he did not eat much. But now feels okay.
Urticaria, hives around vaccine site and across body. No vesicular lesions. Prescribed Lidex 0.05% and Atarax 25mg.
Red knot @ site of DT injection lt upper arm IM. Area was warm & sensitive to touch. DT given 5APR91, in ofc w/rxn 8APR91. Area was 5 X 7 cm
This spontaneous report was received from a office manager (also reported as healthcare worker) refers to patients of unknown age. On an unknown date between 17-FEB-2014 to 21-MAR-2014, the patients were vaccinated with a dose of ROTATEQ, (lot number, expiry date was not reported) which was improperly stored and no adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a 5 year old patient. The medical history, concurrent conditions and concomitant medications were not reported. On 28-OCT-2016 the patient was vaccinated with improperly stored PROQUAD lot # M032497 22-JAN-2018. No adverse effects were reported. Additional information has been requested.
Developed respiratory distress and grunting, 2 hours post vax. Sent to ER for evaluation.
Patient received her second Pfizer covid vaccine on Tuesday 4/6/21. She said she had been doing yard work before she came to get her vaccine. After she received her vaccine she felt fine. On Tuesday night she started to feel some itchiness. She said the itchiness got worse over the next two days. She talked to her husband and he advised her to take Benadryl so she took two Benadryl. On Wednesday she had some soreness at her injection site. Very early Thursday morning she noticed a golf ball sized knot in her armpit. She said it was sore and if she rubbed it, it felt like it was pushing into her breast. She said it felt like pressure going all the way to her breast bone and along her esophagus. She ended up calling EMS and her blood pressure was up to 181/107 and had a high heart rate. She said she never had any hives but did have some throat, tongue, and lip swelling and said that her throat felt raw. The EMS gave her 2 nitroglycerin tablets and 5 aspirin. She spent Friday and Saturday in the hospital. She said the hospital did all kinds of cardiac tests on her and everything can back clear besides a leaky heart valve. She said she is feeling much better now and that the hospital was not sure if it was a reaction to the vaccine, something else, or a combination of things that caused it.
Pt reported rash onset 8/25 or 8/26 on neck, back, chest & abdomen. Describes as pimple like or measles like with pruritus, seen by primary care Dr. "rash very non descript". Felt possible drug reaction from NORVASC started approx 1 wk ago. NORVASC Dc'd.
my heart weas beating normally (lub dub lub dub) my heart then began to beat considerably faster, the beating stopped, swelled, collapsed to normal size, thn began to beat at the regular normal pace...lub dub, lub dub!  the entire process lasted for between 3.5 & 4.0 seconds.
pt recvd 2 doses of Engerix-B & w/in 24 hrs devel generalized arthralgias which last for 48 hrs; immed p/dose 2 was fatigued exp flu-like sx, achiness, & 101 degree low grade fever; also had lower abdominal pain, nausea, back pain;;
given a dose stored out of range; This case was reported by a other health professional via call center representative and described the occurrence of incorrect product storage in a 26-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th October 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incorrect product storage. On an unknown date, the outcome of the incorrect product storage was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, the patient was given a dose of Boostrix that might have been stored out of range, which led to incorrect product storage. The reporter stated that, the tag alert was red but the fridge log did not have any out of range temperatures. Med info was unable to determine viability as the vaccine was ordered from some other facility. The reporter consented to follow up.